Drugs / Influenza Virus Vaccine, Fluzone®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00390884 | Oct 2006 → Jun 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Vaccine, Fluzone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00390884 ↗ |
| Modality | Vaccine | “Influenza Virus Vaccine, Fluzone®” NCT00390884 ↗ |
| Route | Intramuscular | “0.25 mL, Intramuscular” NCT00390884 ↗ |